# Cleveland BioLabs, Inc. (CBLI)

Source: https://www.quantisnow.com/company/CBLI
Generated: 2026-11-18T09:41:52.647Z

- Ticker: CBLI
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Commercial Physical & Biological Resarch
- IPO year: 2006

## Latest CBLI news and filings

- 2021-10-19 20:05 UTC [SEC Form 4] [SEC Form 4: Barbarick Steve K was granted 60,000 shares](https://www.quantisnow.com/insight/sec-form-4-barbarick-steve-k-was-granted-60000-shares-1891128)
- 2021-10-19 20:05 UTC [SEC Form 4] [SEC Form 4: Verny Lea was granted 60,000 shares](https://www.quantisnow.com/insight/sec-form-4-verny-lea-was-granted-60000-shares-1891122)
- 2021-10-12 12:28 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Cleveland BioLabs, Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-cleveland-biolabs-inc-1863769)
- 2021-09-30 20:41 UTC [SEC Form 4] [SEC Form 4: Markvicka Taunia was granted 100,000 shares](https://www.quantisnow.com/insight/sec-form-4-markvicka-taunia-was-granted-100000-shares-1828699)
- 2021-09-29 20:06 UTC [SEC Form 8-K] [Cleveland BioLabs, Inc. filed SEC Form 8-K: Changes in Registrant’s Certifying Accountant, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cleveland-biolabs-inc-filed-sec-form-8-k-changes-in-registrants-1823356)
- 2021-09-28 20:59 UTC [SEC Form 8-K] [Cleveland BioLabs, Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cleveland-biolabs-inc-filed-sec-form-8-k-other-events-financial-1819014)
- 2021-09-10 10:07 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Cleveland BioLabs, Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-cleveland-biolabs-inc-1758912)
- 2021-09-01 13:16 UTC [SEC Form 8-K] [Cleveland BioLabs, Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cleveland-biolabs-inc-filed-sec-form-8-k-amendments-to-articles-1729836)
- 2021-08-31 11:32 UTC [Cytocom, Inc. Announces Plan to Adopt New Corporate Name "Statera BioPharma, Inc."](https://www.quantisnow.com/insight/cytocom-inc-announces-plan-to-adopt-new-corporate-name-statera-1723382)
- 2021-08-17 21:18 UTC [SEC Form 8-K] [Cleveland BioLabs, Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cleveland-biolabs-inc-filed-sec-form-8-k-regulation-fd-disclosure-1680969)
- 2021-08-16 14:34 UTC [Earnings Date] [Cytocom, Inc. Second Quarter 2021 Financial Results Conference Call Replay Available Via Webcast](https://www.quantisnow.com/insight/cytocom-inc-second-quarter-2021-financial-results-conference-call-replay-1672439)
- 2021-08-16 11:31 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Cleveland BioLabs, Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-cleveland-biolabs-inc-1670834)
- 2021-08-16 11:30 UTC [Earnings Date] [Cytocom, Inc. Reports Second Quarter 2021 Financial Results](https://www.quantisnow.com/insight/cytocom-inc-reports-second-quarter-2021-financial-results-1670786)
- 2021-08-16 11:15 UTC [SEC Form 8-K] [Cleveland BioLabs, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cleveland-biolabs-inc-filed-sec-form-8-k-results-of-operations-1670714)
- 2021-08-12 20:05 UTC [Conference Announcement] [Cytocom, Inc. and La Jolla Institute for Immunology Announce Five-Year Research Alliance Agreement](https://www.quantisnow.com/insight/cytocom-inc-and-la-jolla-institute-for-immunology-announce-five-year-1663579)
- 2021-08-11 11:30 UTC [Cytocom, Inc. Announces Participation at Liberty University's Empowering the Kingdom Through Business Conference](https://www.quantisnow.com/insight/cytocom-inc-announces-participation-at-liberty-universitys-empowering-the-kingdom-1654106)
- 2021-08-10 11:30 UTC [Earnings Date] [Cytocom, Inc. to Report Second Quarter 2021 Financial Results](https://www.quantisnow.com/insight/cytocom-inc-to-report-second-quarter-2021-financial-results-1647721)
- 2021-08-09 20:47 UTC [SEC Form 8-K] [Cleveland BioLabs, Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cleveland-biolabs-inc-filed-sec-form-8-k-other-events-financial-1645499)
- 2021-08-09 11:30 UTC [Cytocom Inc. Provides Updates on Key Clinical Programs for Crohn's Disease, Hematology, Pancreatic Cancer and COVID-19](https://www.quantisnow.com/insight/cytocom-inc-provides-updates-on-key-clinical-programs-for-crohns-1641479)
- 2021-08-05 11:33 UTC [Cytocom Inc. Provides Update on Completed Merger with Cleveland BioLabs](https://www.quantisnow.com/insight/cytocom-inc-provides-update-on-completed-merger-with-cleveland-biolabs-1628896)
- 2021-08-04 22:59 UTC [SEC Form 3] [SEC Form 3 filed by Handley Michael K](https://www.quantisnow.com/insight/sec-form-3-filed-by-handley-michael-k-1627081)
- 2021-08-04 23:00 UTC [SEC Form 4] [SEC Form 4: Handley Michael K was granted 296,609 units of Common Stock](https://www.quantisnow.com/insight/sec-form-4-handley-michael-k-was-granted-296609-units-1627080)
- 2021-07-30 15:09 UTC [SEC Form 8-K] [Cleveland BioLabs, Inc. filed SEC Form 8-K: Financial Statements and Exhibits (Amendment)](https://www.quantisnow.com/insight/cleveland-biolabs-inc-filed-sec-form-8-k-financial-statements-and-1563335)
- 2021-07-30 01:33 UTC [SEC Form 4] [SEC Form 4: ARONSTAM PETER was granted 141,370 units of Common Stock](https://www.quantisnow.com/insight/sec-form-4-aronstam-peter-was-granted-141370-units-of-1555459)
- 2021-07-30 01:33 UTC [SEC Form 4] [SEC Form 4: McAvoy Cozette M. was granted 60,947 units of Common Stock](https://www.quantisnow.com/insight/sec-form-4-mcavoy-cozette-m-was-granted-60947-units-1555457)
- 2021-07-30 01:34 UTC [SEC Form 4] [SEC Form 4: Selsky Clifford was granted 101,579 units of Common Stock](https://www.quantisnow.com/insight/sec-form-4-selsky-clifford-was-granted-101579-units-of-1555456)
- 2021-07-30 01:34 UTC [SEC Form 4] [SEC Form 4: Buckheit Robert was granted 24,378 units of Common Stock](https://www.quantisnow.com/insight/sec-form-4-buckheit-robert-was-granted-24378-units-of-1555455)
- 2021-07-30 01:29 UTC [SEC Form 3] [SEC Form 3 filed by Cleveland BioLabs, Inc.](https://www.quantisnow.com/insight/sec-form-3-filed-by-cleveland-biolabs-inc-1555435)
- 2021-07-30 01:29 UTC [SEC Form 3] [SEC Form 3 filed by McAvoy Cozette M.](https://www.quantisnow.com/insight/sec-form-3-filed-by-mcavoy-cozette-m-1555434)
- 2021-07-30 01:30 UTC [SEC Form 3] [SEC Form 3 filed by Barbarick Steve K](https://www.quantisnow.com/insight/sec-form-3-filed-by-barbarick-steve-k-1555433)
- 2021-07-30 01:31 UTC [SEC Form 3] [SEC Form 3 filed by ARONSTAM PETER](https://www.quantisnow.com/insight/sec-form-3-filed-by-aronstam-peter-1555432)
- 2021-07-30 01:31 UTC [SEC Form 3] [SEC Form 3 filed by Selsky Clifford](https://www.quantisnow.com/insight/sec-form-3-filed-by-selsky-clifford-1555431)
- 2021-07-30 01:32 UTC [SEC Form 3] [SEC Form 3 filed by Buckheit Robert](https://www.quantisnow.com/insight/sec-form-3-filed-by-buckheit-robert-1555430)
- 2021-07-28 12:30 UTC [SEC Form 8-K] [Cleveland BioLabs, Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cleveland-biolabs-inc-filed-sec-form-8-k-completion-of-acquisition-1527673)
- 2021-07-23 20:22 UTC [SEC Form 4] [SEC Form 4: Miller Langdon L exercised 10,000 units of Common Stock at a strike of $3.00](https://www.quantisnow.com/insight/sec-form-4-miller-langdon-l-exercised-10000-units-of-1481041)
- 2021-07-06 21:01 UTC [SEC Form 8-K] [Cleveland BioLabs, Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/cleveland-biolabs-inc-filed-sec-form-8-k-leadership-update-submission-1268861)
- 2021-07-06 13:16 UTC [Cleveland BioLabs, Inc. and Cytocom Inc. Announce Call to Discuss Stockholder Meeting Vote Results and Proposed Merger](https://www.quantisnow.com/insight/cleveland-biolabs-inc-and-cytocom-inc-announce-call-to-discuss-1259624)
- 2021-06-17 22:37 UTC [Cleveland BioLabs, Inc. and Cytocom Announce Registration Statement and Proxy Statement  for Previously Announced Merger Declared Effective by SEC](https://www.quantisnow.com/insight/cleveland-biolabs-inc-and-cytocom-announce-registration-statement-and-proxy-1061277)
- 2021-06-17 21:16 UTC [SEC Form 425] [SEC Form 425 filed by Cleveland BioLabs, Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-cleveland-biolabs-inc-1059924)
- 2021-06-11 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Cleveland BioLabs, Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-cleveland-biolabs-inc-983627)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CBLI
- Earnings history: https://www.quantisnow.com/earnings/CBLI
- Dividend history: https://www.quantisnow.com/dividends/CBLI
- Insider transactions: https://www.quantisnow.com/insiders/CBLI
- Options chain: https://www.quantisnow.com/options/CBLI
- SEC 8-K filings only: https://www.quantisnow.com/company/CBLI/8-k
- RSS and alerts for CBLI: https://www.quantisnow.com/docs/rss-feeds.md
